Enhanced Antitumor Effect of Coincident Intravesical Gemcitabine Plus BCG Therapy in an Orthotopic Bladder Cancer Model

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

Cancer Statistics, Epidemiology, Cancer Epidemiology +14

The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7 Years of Followup

David A. Tolley, Mahesh Parmar, Kenneth M. Grigor et al. · The Journal of Urology · 1996 · 324 citations

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.

Malcolm J. Moore, Ian F. Tannock, D. Scott Ernst et al. · Journal of Clinical Oncology · 1997 · 272 citations

Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder

Guido Dalbagni, Paul Russo, Joel Sheinfeld et al. · Journal of Clinical Oncology · 2002 · 259 citations

Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

Anna K. Nowak, Bruce Robinson, Richard Lake · PubMed · 2002 · 241 citations

Combination Chemo-immunotherapy, Humoral Immune Response, Humoral Response +21